Article

Development of a question prompt list to support Consent for Genomic Testing (CoGenT) and research

2026-02-16

Abstract excerpt

<title>Abstract</title> <p>While genomic testing is increasingly utilised to personalise cancer treatment, its complexity creates challenges in achieving informed consent. Partnering with patients, carers, researchers and health professionals, we developed a Question Prompt List (QPL) aiming to support communication and informed consent for tumour profiling and genomic research in oncology. Participants (n = 38)...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: c570ed8a-2f8f-5a84-8e61-c6647c801b97
DOI: 10.21203/rs.3.rs-8674757/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Development of a question prompt list to support Consent for Genomic Testing (CoGenT) and researchDOI 10.21203/rs.3.rs-8674757/v1Read

Informed Consent in Genomic Testing: Healthcare Professionals’ Perceptions on the Value of a Dynamic Consent Platform in Precision OncologySemantic proximity Read

Development and validation of a stakeholder-driven, self-contained electronic informed consent platform for trio-based genomic research studiesSemantic proximity Read

Return of comprehensive tumour genomic profiling results to advanced cancer patients: a qualitative studySemantic proximity Read

Implementing Electronic Informed Consent in Rare Disease GenomicsSemantic proximity Read

Development and Pilot Testing of a Decision Aid for Genomic Research Participants Notified of Clinically Actionable Research Findings for Cancer Risk.Semantic proximity Read

What does a consent conversation for whole genome sequencing look like in the NHS Genomic Medicine Service? An observational studySemantic proximity Read

Defining the Critical Educational Components of Informed Consent for Genetic Testing: Views of US-Based Genetic Counselors and Medical GeneticistsSemantic proximity Read

Whether, when, how, and how much? General public’s and cancer patients’ views about the disclosure of genomic secondary findingsSemantic proximity Read

How do consent forms for diagnostic high‐throughput sequencing address unsolicited and secondary findings? A content analysisSemantic proximity Read

Obtaining informed consent for genomics research in Africa: analysis of H3Africa consent documentsSemantic proximity Read

Not all information is equally important: informed consent to genetic testing for hereditary cancer.Semantic proximity Read

Whether, when, how, and how much? General public’s and cancer patients’ views about the disclosure of genomic secondary findingsSemantic proximity Read